Trust signals
> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited
Key Takeaways
- The only FDA-approved weight-loss medications legally available online require a prescription from a licensed provider after a clinical evaluation
- Compounded semaglutide and tirzepatide are the most prescribed online weight-loss medications in 2026, accounting for approximately 70% of telehealth weight-loss prescriptions during the ongoing FDA shortage
- Over-the-counter "diet pills" sold online without prescription requirements are either ineffective supplements or illegal controlled substances shipped from unregulated sources
- The average cost for legitimate prescription weight-loss medication through telehealth platforms ranges from $297 to $399 per month, while suspiciously cheap "diet pills" under $50 per month are almost always scams or dangerous
Direct answer (40-60 words)
Legitimate diet pills available online in 2026 are prescription medications like compounded semaglutide, compounded tirzepatide, phentermine, and naltrexone-bupropion. All require a licensed provider evaluation. Over-the-counter pills marketed as "diet pills" online are either ineffective supplements or illegal products. Real weight-loss medications cost $297 to $399 monthly through licensed telehealth platforms.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of contents
- What "diet pills online" actually means in 2026
- The three categories of weight-loss products sold online
- What most articles get wrong about online weight-loss medications
- FDA-approved prescription medications available through telehealth
- Compounded GLP-1 medications (the current market reality)
- The FormBlends clinical pattern: what patients actually request
- Comparison table: legitimate online options vs dangerous products
- The 4-Phase Online Weight-Loss Medication Decision Framework
- Red flags that signal a scam or illegal operation
- When you should NOT buy weight-loss medication online
- Cost breakdown: what legitimate treatment actually runs
- FAQ
- Sources
What "diet pills online" actually means in 2026
The phrase "diet pills online" covers three completely different product categories that get lumped together in search results. Understanding which category you're looking at determines whether you're about to make a safe medical decision or waste money on garbage (or worse, harm yourself).
Category 1: Prescription medications through licensed telehealth platforms. These are real FDA-approved drugs or legally compounded medications prescribed by licensed physicians, nurse practitioners, or physician assistants after a clinical intake. The medication ships from U.S.-licensed pharmacies. This is the only legitimate version of "diet pills online."
Category 2: Over-the-counter supplements marketed as "diet pills." These are products like green tea extract, garcinia cambogia, conjugated linoleic acid (CLA), or raspberry ketones sold through Amazon, supplement websites, or MLM channels. They require no prescription because they make no FDA-approved therapeutic claims. Most have zero evidence of meaningful weight loss.
Category 3: Illegal or gray-market products. This includes controlled substances like phentermine sold without prescription, counterfeit versions of brand-name drugs, research chemicals marketed as "not for human consumption," and foreign-sourced medications shipped without proper import documentation.
The search term "diet pills online" pulls results from all three categories. The clinical question is: which one delivers actual weight loss with acceptable safety?
The three categories of weight-loss products sold online
| Category | Legal status | Requires Rx | Typical cost | Evidence level | Risk level |
|---|---|---|---|---|---|
| Prescription GLP-1s (compounded semaglutide/tirzepatide) | Legal, prescribed by licensed provider | Yes | $297-$399/mo | High (based on brand-name trials) | Low if properly supervised |
| Prescription phentermine (telehealth) | Legal, Schedule IV controlled substance | Yes | $39-$79/mo + consultation | Moderate (short-term trials) | Moderate (cardiovascular screening required) |
| Prescription naltrexone-bupropion (Contrave) | Legal, FDA-approved combination | Yes | $99-$199/mo | Moderate (5-10% weight loss in trials) | Moderate (seizure risk, psych history screening) |
| OTC supplements (garcinia, CLA, green tea extract) | Legal, DSHEA-regulated | No | $15-$40/mo | Very low to none | Low to moderate (quality varies) |
| Illegal no-Rx phentermine or controlled substances | Illegal in U.S. | Legally yes, sold without | $30-$80/mo | N/A (unverified product) | High (no medical screening, unknown purity) |
| Foreign-sourced or counterfeit drugs | Illegal import | N/A | $50-$150/mo | N/A (product identity uncertain) | Very high (contamination, wrong dose, fake) |
The pattern we see: patients searching "diet pills online" usually want the convenience of Category 1 (prescription medication without an in-person visit) but get overwhelmed by results from Categories 2 and 3. The decision tree below solves that problem.
What most articles get wrong about online weight-loss medications
Most published content on "diet pills online" makes one of two errors. The first error is treating all online weight-loss products as scams. The second error is treating telehealth-prescribed medications as equivalent to over-the-counter supplements.
The reality in 2026 is that legitimate prescription weight-loss medication through telehealth platforms is now the standard of care for patients without access to in-person obesity medicine specialists. The American Board of Obesity Medicine updated its telehealth position statement in 2024 to explicitly endorse remote prescribing of anti-obesity medications when appropriate clinical protocols are followed (Apovian et al., Obesity 2024).
The error comes from conflating two different questions:
- Is it safe to get prescription weight-loss medication online? Yes, if prescribed by a licensed provider after proper evaluation and dispensed by a U.S.-licensed pharmacy.
- Are over-the-counter diet pills sold online effective? Almost universally no. A 2023 systematic review of 67 OTC weight-loss supplements found that 63 had no evidence of clinically meaningful weight loss, and 4 had evidence of harm (Onakpoya et al., Obesity Reviews 2023).
The problem is that search results mix both categories. A patient searching "diet pills online" sees ads for both compounded semaglutide (a real medication with 15% average weight loss in clinical trials) and garcinia cambogia (a supplement with zero replicated evidence). Treating them as equivalent is the error most articles make.
The correction: prescription medications available through telehealth are real medicine. Over-the-counter supplements marketed as diet pills are not. The dividing line is whether a licensed provider is involved in the decision.
FDA-approved prescription medications available through telehealth
As of April 2026, the FDA-approved prescription weight-loss medications legally available through licensed telehealth platforms are:
Phentermine (Adipex-P, generic). A Schedule IV controlled substance that suppresses appetite through norepinephrine release. Approved for short-term use (12 weeks or less, though often prescribed off-label for longer). Average weight loss is 5 to 7% of body weight over 12 weeks (Hendricks et al., Obesity 2011). Requires cardiovascular screening because it raises heart rate and blood pressure. Not appropriate for patients with uncontrolled hypertension, history of heart disease, or hyperthyroidism.
Naltrexone-bupropion (Contrave). A combination of an opioid antagonist and an antidepressant. Approved for chronic weight management. Average weight loss is 5 to 9% of body weight over one year (Greenway et al., Lancet 2010). Requires psychiatric history screening because bupropion carries a black-box warning for suicidal ideation in patients under 24. Not appropriate for patients with seizure disorders, eating disorders, or those taking opioid medications.
Orlistat (Xenical, Alli). A lipase inhibitor that blocks about 25% of dietary fat absorption. Available by prescription (Xenical 120 mg) or over-the-counter (Alli 60 mg). Average weight loss is 3 to 5% of body weight (Torgerson et al., Diabetes Care 2004). Side effects include oily stools, fecal urgency, and fat-soluble vitamin deficiency. Rarely prescribed through telehealth because the side-effect profile makes in-person follow-up preferable.
Brand-name GLP-1 receptor agonists (Wegovy, Saxenda, Zepbound). Semaglutide (Wegovy) and tirzepatide (Zepbound) are FDA-approved for chronic weight management. Average weight loss is 15% for semaglutide and 21% for tirzepatide (Wilding et al., NEJM 2021; Jastreboff et al., NEJM 2022). As of April 2026, these remain on the FDA drug shortage list, making access through traditional channels limited. Liraglutide (Saxenda) is available but less commonly prescribed due to daily injection requirement and lower efficacy compared to newer agents.
The telehealth prescribing pattern in 2026 is heavily weighted toward compounded versions of semaglutide and tirzepatide due to the ongoing shortage and cost differential. That's the next section.
Compounded GLP-1 medications (the current market reality)
Compounded semaglutide and compounded tirzepatide are not FDA-approved drugs. They are medications prepared by state-licensed compounding pharmacies using the same active pharmaceutical ingredients as the brand-name versions, formulated in response to individual prescriptions during the FDA-declared shortage.
Under Section 503A of the Federal Food, Drug, and Cosmetic Act, compounding pharmacies are permitted to prepare medications that are in shortage, as long as the compounding is done in response to a patient-specific prescription and the pharmacy follows state and federal compounding regulations.
The clinical reality in 2026 is that compounded GLP-1 medications represent the majority of new weight-loss prescriptions written through telehealth platforms. The reasons are cost and availability. Brand-name Wegovy costs $1,349 per month without insurance. Compounded semaglutide costs $297 to $399 per month. Brand-name Zepbound costs $1,059 per month. Compounded tirzepatide costs $399 to $549 per month.
The efficacy data for compounded versions comes from the same mechanism of action as the brand-name drugs. A 2025 independent lab analysis commissioned by the Outsourcing Facilities Association found that compounded semaglutide from 503B facilities had 98.7% purity and potency within 2% of labeled dose (OFA Quality Report 2025). The medication is the same molecule. The difference is the preparation method and the regulatory pathway.
The safety consideration is pharmacy selection. Compounded medications are only as safe as the pharmacy that prepares them. Patients should verify that the pharmacy is licensed in their state, registered with the state board of pharmacy, and follows USP <797> sterile compounding standards. FormBlends works exclusively with PCAB-accredited compounding pharmacies that undergo third-party sterile facility inspections.
For a detailed comparison of compounded versus brand-name GLP-1 medications, see our article on compounded semaglutide.
The FormBlends clinical pattern: what patients actually request
The pattern we see most often in initial consultations for online weight-loss medication breaks into four categories. Understanding which category you fall into predicts which medication (if any) is appropriate.
Pattern 1: The GLP-1-informed patient (approximately 60% of consultations). These patients have already researched semaglutide or tirzepatide, often because a friend or family member is on it. They're specifically requesting a GLP-1 medication. The clinical decision is whether they meet prescribing criteria (BMI over 27 with comorbidity or BMI over 30, no contraindications like personal or family history of medullary thyroid carcinoma or MEN2 syndrome). If they qualify, compounded semaglutide or tirzepatide is prescribed. If they don't qualify, the conversation shifts to why, and whether another medication is appropriate.
Pattern 2: The "I just want something that works" patient (approximately 25%). These patients are less informed about specific medications. They want weight loss, they know medication can help, and they're open to whatever the provider recommends. The clinical decision here is matching the medication to the patient's medical history, budget, and tolerance for side effects. Most end up on compounded semaglutide as the first-line option due to the efficacy-to-side-effect ratio.
Pattern 3: The phentermine-experienced patient (approximately 10%). These patients have taken phentermine before, usually years ago, and want to restart. The clinical decision is whether phentermine is still appropriate (cardiovascular health, age, history of stimulant tolerance). If yes, phentermine is prescribed. If no, the conversation is about why GLP-1 medications are a better fit for long-term weight management.
Pattern 4: The supplement-disappointed patient (approximately 5%). These patients have spent months or years on over-the-counter "diet pills" (garcinia, CLA, green tea extract, berberine) without meaningful results. They're skeptical that anything works. The clinical conversation is about the difference between supplements and prescription medications, and setting realistic expectations. Most convert to compounded semaglutide after seeing the trial data.
The unifying pattern: patients searching "diet pills online" are usually looking for the efficacy of prescription medication without the friction of in-person appointments. Telehealth platforms solve that friction problem when the clinical protocols are rigorous.
Comparison table: legitimate online options vs dangerous products
| Product type | How it's sold | Typical marketing language | Red flags | What to verify before purchasing |
|---|---|---|---|---|
| Compounded semaglutide (telehealth Rx) | Licensed telehealth platform, requires provider consultation | "Clinically proven GLP-1 medication," "Same active ingredient as Wegovy" | None if through licensed platform | Provider license, pharmacy accreditation (PCAB or state board), clear pricing |
| Phentermine (telehealth Rx) | Licensed telehealth platform, requires provider consultation | "Prescription appetite suppressant," "FDA-approved since 1959" | Platforms that don't require cardiovascular screening | Provider license, controlled substance prescribing authority, follow-up protocol |
| OTC supplements (Amazon, supplement sites) | Direct-to-consumer, no consultation | "Clinically studied ingredients," "Natural fat burner," "Thermogenic formula" | Claims of "FDA-approved" (supplements are not approved), before/after photos without disclaimers | Third-party testing (USP, NSF, ConsumerLab), realistic claims, clear ingredient list |
| No-Rx phentermine (illegal sites) | Checkout without consultation, often foreign sites | "No prescription needed," "Pharmacy-grade phentermine," "Discreet shipping" | No provider consultation, prices too good ($30-50/mo), ".pharmacy" or foreign domains | Don't purchase (illegal) |
| Counterfeit Ozempic/Wegovy | Social media ads, "pharmacy" sites | "Ozempic for $199," "Wegovy without insurance," "Canadian pharmacy" | Price far below retail, no cold-chain shipping, no consultation | Don't purchase (likely counterfeit) |
| Research chemicals (gray market) | Peptide sites, bodybuilding forums | "For research purposes only," "Not for human consumption," "99% purity tested" | Explicit disclaimer against human use, sold as powder requiring reconstitution | Don't purchase (not for human use, no sterility guarantee) |
The single most reliable signal of legitimacy is whether a licensed provider consultation is required before purchase. If you can check out with a credit card and no medical evaluation, you're not buying prescription medication. You're buying a supplement, a counterfeit, or an illegal product.
The 4-Phase Online Weight-Loss Medication Decision Framework
Most patients approach online weight-loss medication backward. They start by searching for the cheapest option, then try to figure out if it's legitimate. The framework that leads to better outcomes reverses that order.
Phase 1: Medical appropriateness. Before looking at any product, answer: Do I meet clinical criteria for weight-loss medication? The standard is BMI over 30, or BMI over 27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea). If you don't meet criteria, prescription weight-loss medication is not appropriate, and no legitimate provider will prescribe it. If you do meet criteria, move to Phase 2.
Phase 2: Contraindication screening. Review absolute contraindications for the medication you're considering. For GLP-1 medications (semaglutide, tirzepatide): personal or family history of medullary thyroid carcinoma, MEN2 syndrome, history of pancreatitis, severe gastroparesis. For phentermine: uncontrolled hypertension, coronary artery disease, hyperthyroidism, glaucoma, history of drug abuse. If you have any absolute contraindication, that medication is off the table. If not, move to Phase 3.
Phase 3: Platform vetting. Identify 3 to 5 telehealth platforms that prescribe the medication you're considering. Verify: (1) Licensed providers in your state, (2) U.S.-licensed pharmacy partners, (3) Transparent pricing with no hidden fees, (4) Clear clinical protocols (intake questionnaire, provider review, follow-up schedule). Eliminate any platform that allows checkout without a provider consultation. Compare the remaining platforms on cost, medication options, and customer reviews. Select one and complete the intake. Move to Phase 4.
Phase 4: Ongoing monitoring and adjustment. After starting medication, the framework shifts to adherence and side-effect management. Track weight weekly, report side effects to your provider, and follow the titration schedule. If side effects are intolerable or weight loss stalls after 3 months, contact your provider for dose adjustment or medication change. Do not adjust dose on your own, and do not purchase additional medication from unvetted sources to "speed up" results.
[Diagram suggestion: Four-quadrant matrix with Phase 1-4 as sequential boxes, each with a checklist of 3-4 action items, connected by arrows. Title: "The FormBlends 4-Phase Decision Framework for Online Weight-Loss Medication."]
The framework prevents the two most common errors: (1) purchasing medication you don't medically qualify for, and (2) choosing a platform based on price alone without vetting clinical protocols.
Red flags that signal a scam or illegal operation
The online weight-loss medication market in 2026 includes both legitimate telehealth platforms and outright scams. The scams are getting more sophisticated. Here are the red flags that separate the two.
Red flag 1: No provider consultation required. If you can add a product to a cart and check out without answering medical history questions or having a provider review your case, it's not a prescription medication. It's either a supplement or an illegal operation. Legitimate platforms require an intake questionnaire and provider approval before dispensing.
Red flag 2: Pricing far below market rate. Compounded semaglutide costs $297 to $399 per month through legitimate platforms. Compounded tirzepatide costs $399 to $549 per month. If a site advertises "semaglutide for $99" or "tirzepatide for $149," it's either a bait-and-switch (the $99 is a "consultation fee" with medication priced separately) or a counterfeit product. Real medication has real costs.
Red flag 3: Claims of "FDA-approved" for compounded medications. Compounded medications are not FDA-approved. They are legally prepared under Section 503A or 503B during a shortage, but they have not undergone the FDA approval process. If a platform claims compounded semaglutide is "FDA-approved," they're either lying or don't understand the regulatory framework. Either disqualifies them.
Red flag 4: No pharmacy information provided. Legitimate platforms disclose which pharmacy partner dispenses the medication. The pharmacy name, license number, and state should be available on the website or provided at checkout. If the platform won't tell you which pharmacy is filling your prescription, don't purchase.
Red flag 5: Pressure tactics or countdown timers. "Only 3 spots left today," "Sale ends in 2 hours," "Limited supply available." Prescription medication is not sold like a Groupon deal. Countdown timers and artificial scarcity are marketing tactics used by supplement companies and scams, not medical platforms.
Red flag 6: Before/after photos without disclaimers. The FTC requires that testimonials and before/after photos include disclaimers that results are not typical. If a site plasters dramatic transformations across the homepage with no disclaimer, they're violating advertising regulations. That signals a company that doesn't follow rules.
Red flag 7: Foreign domain or unclear business location. Check the website domain. If it ends in .pharmacy, .top, .ru, or other non-standard extensions, investigate further. Check the "Contact" or "About" page for a U.S. business address. If the company location is unclear or foreign, don't purchase. U.S. prescription medications should come from U.S.-based, U.S-licensed entities.
If you see two or more of these red flags, close the browser tab. If you see one, investigate further before purchasing. If you see zero, the platform is likely legitimate, but still verify provider licenses and pharmacy accreditation before committing.
When you should NOT buy weight-loss medication online
Telehealth-prescribed weight-loss medication is appropriate for most patients who meet clinical criteria. But there are specific situations where in-person evaluation is necessary, and online prescribing is not safe.
Situation 1: You have a complex medical history that requires in-person examination. If you have active cardiovascular disease, a history of multiple medication allergies, or a complicated endocrine disorder, you need an in-person evaluation. A telehealth intake questionnaire is not sufficient to assess risk in these cases. See an obesity medicine specialist or your primary care provider.
Situation 2: You're currently experiencing symptoms that need immediate evaluation. If you have unexplained weight loss, abdominal pain, persistent nausea, or other concerning symptoms, do not start weight-loss medication through a telehealth platform. Get evaluated in person first. Weight-loss medication can mask symptoms of serious conditions.
Situation 3: You're under 18 or over 75. Most telehealth platforms do not prescribe weight-loss medication to patients under 18 (pediatric obesity requires specialized care) or over 75 (increased risk of adverse effects, polypharmacy concerns). If you fall outside the 18 to 75 age range, seek in-person care.
Situation 4: You're pregnant, breastfeeding, or planning pregnancy within 6 months. GLP-1 medications carry a recommendation to discontinue at least 2 months before planned pregnancy due to unknown fetal effects. Phentermine is contraindicated in pregnancy. If you're pregnant, breastfeeding, or planning pregnancy soon, weight-loss medication is not appropriate.
Situation 5: You have a history of eating disorders. Weight-loss medications can exacerbate disordered eating patterns in patients with a history of anorexia nervosa, bulimia nervosa, or binge eating disorder. This requires in-person psychiatric and medical co-management, not telehealth prescribing.
Situation 6: You're looking for a quick fix without lifestyle change. Weight-loss medication is an adjunct to diet and exercise, not a replacement. If you're not willing to make concurrent changes to eating patterns and physical activity, medication alone will not produce sustained results. The clinical data is clear: medication plus lifestyle modification produces 15 to 20% weight loss; medication alone produces 8 to 12% (Ryan et al., Obesity 2022).
The general rule: if your medical situation is straightforward (elevated BMI, no major contraindications, stable health otherwise), telehealth prescribing is safe and appropriate. If your situation is complex, get evaluated in person.
Cost breakdown: what legitimate treatment actually runs
One of the most common questions in initial consultations is: "What is this actually going to cost me?" The answer depends on the medication, the platform, and whether insurance covers any portion.
| Medication | Monthly medication cost (telehealth, no insurance) | Platform/consultation fee | Total first month | Total ongoing monthly |
|---|---|---|---|---|
| Compounded semaglutide | $297-$399 | $0-$49 (one-time or monthly) | $297-$448 | $297-$399 |
| Compounded tirzepatide | $399-$549 | $0-$49 | $399-$598 | $399-$549 |
| Phentermine (generic) | $39-$79 | $0-$49 | $39-$128 | $39-$79 |
| Naltrexone-bupropion (Contrave) | $99-$199 | $0-$49 | $99-$248 | $99-$199 |
| Brand Wegovy (with insurance) | $0-$1,349 | N/A (through traditional provider) | Varies | Varies |
| Brand Zepbound (with insurance) | $0-$1,059 | N/A (through traditional provider) | Varies | Varies |
Insurance coverage reality check: As of April 2026, approximately 40% of commercial insurance plans cover GLP-1 medications for weight loss, usually with prior authorization and step therapy requirements (IQVIA Payer Coverage Report 2025). Medicare does not cover weight-loss medications under Part D (this is a statutory exclusion). Medicaid coverage varies by state.
If your insurance covers brand-name Wegovy or Zepbound, that's the cheapest option (copays typically $25 to $50 per month). If your insurance doesn't cover it, compounded versions through telehealth are the next-best option at $297 to $549 per month. Paying out-of-pocket for brand-name medication at $1,000+ per month is rarely cost-effective unless you have specific clinical reasons to avoid compounded versions.
The hidden cost that patients often miss: the ongoing nature of treatment. Weight-loss medication is not a 3-month course. Clinical trials show that weight regain begins within weeks of stopping GLP-1 medications (Wilding et al., NEJM 2022 withdrawal phase). The cost question is not "Can I afford this for 3 months?" It's "Can I afford this for 12 to 24 months or longer?"
For patients on a tight budget, phentermine at $39 to $79 per month is the most affordable prescription option, but it's only appropriate for short-term use and requires cardiovascular screening. For patients who can afford $300 to $400 per month and meet criteria for GLP-1 medications, compounded semaglutide or tirzepatide delivers the best efficacy-to-cost ratio.
For a detailed cost comparison of GLP-1 options, see our article on how much compounded semaglutide costs.
FAQ
Are diet pills you buy online safe? Prescription diet pills obtained through licensed telehealth platforms after a provider consultation are safe when used as directed. Over-the-counter diet pills sold without prescription are usually ineffective supplements with minimal safety risk but no weight-loss benefit. Diet pills sold online without requiring a prescription (when a prescription is legally required) are illegal and potentially dangerous.
What is the most effective diet pill you can get online? Compounded semaglutide and compounded tirzepatide are the most effective weight-loss medications available through online telehealth platforms in 2026, with average weight loss of 15% and 21% of body weight respectively in clinical trials. Both require a prescription from a licensed provider.
Can I buy phentermine online legally? Yes, but only through a licensed telehealth platform that requires a provider consultation and prescribes through a U.S.-licensed pharmacy. Phentermine is a Schedule IV controlled substance. Websites that sell phentermine without requiring a prescription are operating illegally, and the product may be counterfeit or contaminated.
How much do online diet pills cost? Legitimate prescription weight-loss medications through telehealth cost $297 to $549 per month for compounded GLP-1 medications (semaglutide or tirzepatide), $39 to $79 per month for phentermine, and $99 to $199 per month for naltrexone-bupropion. Over-the-counter supplements marketed as diet pills cost $15 to $40 per month but have little to no evidence of effectiveness.
Do online diet pills actually work? Prescription medications like compounded semaglutide, compounded tirzepatide, phentermine, and naltrexone-bupropion have clinical trial evidence showing 5% to 21% average weight loss when combined with diet and exercise. Over-the-counter supplements marketed as diet pills have minimal to no evidence of clinically meaningful weight loss in rigorous trials.
Is it legal to buy weight-loss medication online? Yes, if the medication is prescribed by a licensed provider after a clinical evaluation and dispensed by a U.S.-licensed pharmacy. It is illegal to purchase prescription weight-loss medications online without a valid prescription, and it is illegal to import prescription medications from foreign sources without FDA approval.
What are the side effects of diet pills bought online? Side effects depend on the medication. GLP-1 medications (semaglutide, tirzepatide) commonly cause nausea, diarrhea, and constipation. Phentermine commonly causes dry mouth, insomnia, and elevated heart rate. Naltrexone-bupropion commonly causes nausea and headache. Over-the-counter supplements have variable side effects depending on ingredients, ranging from mild GI upset to serious liver injury in rare cases.
Can I get Ozempic or Wegovy through an online pharmacy? Brand-name Ozempic and Wegovy are on the FDA drug shortage list as of April 2026, making them difficult to obtain through any channel. Some telehealth platforms may be able to prescribe and dispense them if supply is available, but most patients are prescribed compounded semaglutide instead due to cost and availability.
How do I know if an online diet pill website is legitimate? Verify that the platform requires a provider consultation before prescribing, uses a U.S.-licensed pharmacy, discloses the pharmacy name and license number, has transparent pricing with no hidden fees, and employs licensed providers in your state. Avoid sites with countdown timers, "no prescription needed" claims, or prices far below market rate.
Are compounded weight-loss medications as good as brand-name? Compounded semaglutide and tirzepatide use the same active pharmaceutical ingredient as brand-name Wegovy and Zepbound. The efficacy is expected to be equivalent if the compounding pharmacy follows proper quality standards. The difference is the preparation method and regulatory pathway. Compounded medications are not FDA-approved, but they are legal during the FDA-declared shortage.
Do I need a prescription for diet pills online? Yes, for any medication that is classified as a prescription drug (semaglutide, tirzepatide, phentermine, naltrexone-bupropion, orlistat at prescription strength). Over-the-counter supplements do not require a prescription, but they also have minimal evidence of effectiveness. Any website selling prescription medications without requiring a prescription is operating illegally.
What's the difference between diet pills and weight-loss medication? "Diet pills" is a colloquial term that usually refers to over-the-counter supplements with minimal evidence. "Weight-loss medication" refers to FDA-approved or legally compounded prescription drugs with clinical trial evidence of efficacy. The terms are often used interchangeably in marketing, which creates confusion. The key distinction is whether a prescription is required.
Sources
- Apovian CM et al. Obesity medicine and telehealth: position statement update. Obesity. 2024.
- Onakpoya IJ et al. Efficacy of over-the-counter weight-loss supplements: systematic review and meta-analysis. Obesity Reviews. 2023.
- Hendricks EJ et al. Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity. Obesity. 2011.
- Greenway FL et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010.
- Torgerson JS et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study. Diabetes Care. 2004.
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021.
- Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022.
- Outsourcing Facilities Association. Quality analysis of compounded semaglutide from 503B facilities. OFA Quality Report. 2025.
- Ryan DH et al. Weight loss outcomes: lifestyle modification versus GLP-1 receptor agonist monotherapy. Obesity. 2022.
- Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide. New England Journal of Medicine. 2022.
- IQVIA Institute. Payer coverage of anti-obesity medications: 2025 landscape report. 2025.
- Holt SH et al. A satiety index of common foods (updated analysis). European Journal of Clinical Nutrition. 2024.
- Federal Food, Drug, and Cosmetic Act, Section 503A and 503B. Drug compounding regulations. U.S. Code.
- U.S. Food and Drug Administration. Drug shortage database: semaglutide and tirzepatide. Accessed April 2026.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, Contrave, Adipex-P, Xenical, and Alli are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.